Biogen (BIIB) Sale and Maturity of Investments (2009 - 2026)
Biogen's Sale and Maturity of Investments - Total was $55 million in Q3 2026, down 2.8% from $56.6 million a year earlier and down 96.4% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) Sale and Maturity of Investments (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Biogen's Sale and Maturity of Investments - Total was $2.2 billion through Sep 30, 2026; for FY2025, it was $79.7 million, down 44.9% from FY2024.
- Sale and Maturity of Investments - Total shows a five-year compound annual growth rate of -59.6% (FY2020 to FY2025).
- In earlier years, Sale and Maturity of Investments - Total was $144.7 million in FY2024 (-98.1%), $7.5 billion in FY2023 (+104.3%), $3.67 billion in FY2022 (+4.9%) and $3.5 billion in FY2021 (-52.6%).
- Quarterly Sale and Maturity of Investments - Total has moved between -$8.16 billion (Q4 2023) and $5.7 billion (Q3 2023) over five years.
- The best year-over-year quarter for Sale and Maturity of Investments - Total over five years was Q3 2023 (growth of 247.0%); the worst was Q3 2024 (a decline of 99.3%).
- Per Business Quant data, BIIB's Sale and Maturity of Investments - Total in the three quarters before Q3 2026 was $1.52 billion (Q2 2026), $625.7 million (Q1 2026) and $100,000 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Investments Sold (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 308.00 Mn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | - |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 405.00 Mn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | 88.00 Mn |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | - |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 2.53 Bn |
| 10 | Biogen | 37.46 Bn | 26.77 Bn | 2.06 Bn | 55.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 55.00 Mn |
| Jun 30, 2026 | 1.52 Bn |
| Mar 31, 2026 | 625.20 Mn |
| Dec 31, 2025 | 23.10 Mn |
| Sep 30, 2025 | 56.60 Mn |
| Dec 31, 2024 | -358.80 Mn |
| Sep 30, 2024 | 39.20 Mn |
| Jun 30, 2024 | 408.70 Mn |
| Mar 31, 2024 | 55.60 Mn |
| Dec 31, 2023 | -8.16 Bn |
| Sep 30, 2023 | 5.70 Bn |
| Jun 30, 2023 | 3.41 Bn |
| Mar 31, 2023 | 847.20 Mn |
| Dec 31, 2022 | -3.53 Bn |
| Sep 30, 2022 | 1.64 Bn |
| Jun 30, 2022 | 2.83 Bn |
| Mar 31, 2022 | 543.60 Mn |
| Dec 31, 2021 | -648.50 Mn |
| Sep 30, 2021 | 575.40 Mn |
| Jun 30, 2021 | 633.50 Mn |
API Access
Biogen Sale and Maturity of Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "sale-and-maturity-of-investments", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();